Drug Shortage Report for FLUVIRAL
| Report ID | 24232 |
| Drug Identification Number | 02420686 |
| Brand name | FLUVIRAL |
| Common or Proper name | Trivalent Influenza Vaccine (Split Virion, Inactivated) |
| Company Name | ID BIOMEDICAL CORPORATION OF QUEBEC |
| Market Status | DORMANT |
| Active Ingredient(s) | HAEMAGGLUTININ-STRAIN B HAEMAGGLUTININ-STRAIN A HAEMAGGLUTININ-STRAIN A |
| Strength(s) | 15MCG 15MCG 15MCG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 1 vial X 10 doses |
| ATC code | J07BB |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2017-09-27 |
| Actual start date | 2017-09-27 |
| Estimated end date | 2018-03-30 |
| Actual end date | 2018-03-30 |
| Shortage status | Resolved |
| Updated date | 2018-07-13 |
| Company comments | 2017-2018 flu vaccine production less that anticipated. Supply disruption in the private market. Doses reserved for public vaccination programs. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | GlaxoSmithKline Customer Service: 1 800 387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2018-07-13 | English | Compare |
| v3 | 2018-03-31 | English | Compare |
| v2 | 2017-10-03 | French | Compare |
| v1 | 2017-10-03 | English | Compare |
Showing 1 to 4 of 4